Soligenix, Inc. (SNGX)

1.56 -0.09 (-5.45%) USD  |  NASDAQ  |  Dec 15, 16:00
1.59 +0.03 (+1.92%) After-Hours: 17:35
More

Soligenix EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for SNGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Amicus Therapeutics, Inc. --
Insmed, Inc. --
Tonix Pharmaceuticals Holding Corp. --
Citius Oncology, Inc. --